National Library of Finland
Open Data and Linked Data Service
Search works, persons, organizations and subjects:
Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone
URI:
http://urn.fi/URN:NBN:fi:bib:me:W00527224300
about
aikuistyypin diabetes
lääkehoito
lääkkeet
author
Kalliokoski, Annikka
inLanguage
en
isPartOf
Fennica
name
Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone
P60049
<http://rdaregistry.info/termList/RDAContentType/1020>
Instances
-
-
2008 : Annikka Kalliokoski
2008 : Helsingin yliopisto, e-book
Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone
URI:
http://urn.fi/URN:NBN:fi:bib:me:I00527224301
description
Myös verkkoaineistona ISBN 978-952-10-5040-4 (PDF)
isPartOf
Fennica
name
Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone
Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone
URI:
http://urn.fi/URN:NBN:fi:bib:me:I00565042601
description
Myös painettuna ISBN 978-952-92-4630-4
isPartOf
Fennica
name
Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone
View this in Finna
Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone
URI:
http://urn.fi/URN:NBN:fi:bib:me:I00527224300
datePublished
2008
description
5 excerpts.
Artikkeliväitöskirjan yhteenveto-osa ja 5 eripainosta.
kuvitettu
identifier
propertyID:
FI-FENNI
value:
908091
propertyID:
FI-MELINDA
value:
005272243
propertyID:
skl
value:
fx908091
isbn
9789529246304
isPartOf
Fennica
name
Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone
numberOfPages
81, [48] sivu
P60048
<http://rdaregistry.info/termList/RDACarrierType/1049>
P60050
<http://rdaregistry.info/termList/RDAMediaType/1007>
publication
location:
Espoo
organizer:
Annikka Kalliokoski
publisher
Annikka Kalliokoski
View this in Finna
Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone
URI:
http://urn.fi/URN:NBN:fi:bib:me:I00565042600
bookFormat
<http://schema.org/EBook>
datePublished
2008
description
Artikkeliväitöskirjan yhteenveto-osa.
Ei sisällä painetun julkaisun eripainoksia.
Kuvailun perusta: Nimeke nimiönäytöstä.
Nimeke PDF-nimiösivulta.
identifier
propertyID:
FI-FENNI
value:
908086
propertyID:
FI-MELINDA
value:
005650426
propertyID:
skl
value:
fx908086
isbn
9789521050404
isPartOf
Fennica
name
Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone
numberOfPages
1 PDF-tiedosto (81 s.)
P60048
<http://rdaregistry.info/termList/RDACarrierType/1018>
P60050
<http://rdaregistry.info/termList/RDAMediaType/1003>
publication
location:
Helsinki
organizer:
Helsingin yliopisto
publisher
Helsingin yliopisto
url
<http://urn.fi/URN:ISBN:978-952-10-5040-4>
Download this resource as RDF:
Turtle
RDF/XML
N-Triples
JSON-LD